Exploring the Impact of Intestinal Fluid Components on the Solubility and Supersaturation of Danazol
article
OA: green
CC0
AI-generated summary
This study investigated how components within intestinal fluid affect the solubility and supersaturation of danazol, a medication used to treat endometriosis and fibroids.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Eleven simulated intestinal fluids (SIF) were designed using a Design of Experiment (DoE) approach. The DoE SIF covered a range of compositions of fasted state human intestinal fluid (FaHIF) with regard to pH, bile salt (BS), and phospholipid (PL). Using the model compound danazol, the apparent crystalline solubility (aCS) and apparent amorphous solubility (aAS), as well as the supersaturation propensity was determined in the DoE SIF media. The aCS of danazol was dependent on the composition of the SIF, with PL as the main factor, and a small effect from BS and an interaction between BS and PL. From the DoE solubility data a model was derived, which could predict aCS in commercially available SIF (FaSSIF-V1 and -V2) and in a range of FaHIF. The aAS of danazol was differently affected by the SIF composition than the aCS; PL was again the main factor influencing the aAS, but interactions between BS and pH, as well as pH and PL were also important. The supersaturation propensities of danazol in the DoE SIF media were affected by the same factors as the aCS. Hence, the supersaturation behaviour and aCS of danazol, were found to be closely related.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (66)
- A dynamic in vitro lipolysis model via openalex
- A liquid chromatographic method for the determination of danazol in human serum via openalex
- Danazol. A synthetic steroid with diverse biologic effects. via openalex
- Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug via openalex
- Formulation of a Danazol Cocrystal with Controlled Supersaturation Plays an Essential Role in Improving Bioavailability via openalex
- Impact of Polymers on the Precipitation Behavior of Highly Supersaturated Aqueous Danazol Solutions via openalex
- doi:10.1023/a:1012107801889 via openalex
- doi:10.1023/a:1007516718048 via openalex
- doi:10.1016/j.ejps.2011.04.016 via openalex
- doi:10.1023/a:1011910801212 via openalex
- doi:10.1021/cg301679h via openalex
- doi:10.1211/jpp.58.8.0009 via openalex
- doi:10.1016/j.ejpb.2020.04.017 via openalex
- doi:10.1016/j.addr.2016.03.006 via openalex
- doi:10.1002/jps.21903 via openalex
- doi:10.1007/s11095-011-0506-6 via openalex
- doi:10.1002/jps.22643 via openalex
- doi:10.1002/jps.22760 via openalex
- doi:10.14227/dt170310p6 via openalex
- doi:10.3109/10837451003774377 via openalex
- doi:10.1023/a:1007576713216 via openalex
- W2979255838 via openalex
- W3214760094 via openalex
- W4285719527 via openalex
- W6676380689 via openalex
- W6721692848 via openalex
- W6736942966 via openalex
- doi:10.1080/17425247.2016.1218465 via openalex
- doi:10.1002/jps.22154 via openalex
- doi:10.1016/j.ejps.2017.10.003 via openalex
- doi:10.1016/j.ejpb.2020.06.011 via openalex
- doi:10.1007/s11095-009-9857-7 via openalex
- doi:10.1021/ja01084a069 via openalex
- doi:10.14227/dt200313p44 via openalex
- doi:10.1016/j.xphs.2016.06.016 via openalex
- doi:10.1021/mp100144v via openalex
- doi:10.1016/j.ejps.2016.05.026 via openalex
- doi:10.1016/j.ejps.2013.10.015 via openalex
- doi:10.1016/j.ejps.2013.08.027 via openalex
- doi:10.1021/acs.molpharmaceut.7b00419 via openalex
- doi:10.1023/b:pham.0000016283.87709.a9 via openalex
- doi:10.1002/jps.24603 via openalex
- doi:10.1016/j.ejps.2009.10.005 via openalex
- doi:10.1002/jps.10329 via openalex
- doi:10.1002/jps.21502 via openalex
- doi:10.1007/s11095-014-1567-0 via openalex
- doi:10.1023/a:1015877929381 via openalex
- doi:10.1007/s11095-007-9363-8 via openalex
- doi:10.1515/zpch-1926-11927 via openalex
- doi:10.1007/s11095-010-0269-5 via openalex
- doi:10.1016/j.ejps.2014.10.019 via openalex
- doi:10.1002/jps.24090 via openalex
- doi:10.1007/s11095-018-2441-2 via openalex
- doi:10.1023/a:1007517414200 via openalex
- doi:10.1002/jps.10158 via openalex
- doi:10.1021/js960085v via openalex
- doi:10.1038/124119a0 via openalex
- doi:10.1002/jps.20553 via openalex
- doi:10.1002/jps.23306 via openalex
- doi:10.1007/s11095-005-8192-x via openalex
- doi:10.1023/a:1016212804288 via openalex
- doi:10.1016/s0005-2736(00)00309-6 via openalex
- doi:10.1007/s11095-005-8476-1 via openalex
- doi:10.1111/j.2042-7158.2010.01023.x via openalex
- doi:10.1002/jps.21650 via openalex
- doi:10.1023/a:1015827908309 via openalex
SciLite annotations
chemicals 6
danazol
bile salt
phospholipid
danazol
danazol
danazol
organisms 1
human
Source provenance
- openalex
- last seen: 2026-05-11T06:12:37.668444+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
License: CC0
· commercial use OK